MedTrace Logo

Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians

NCT06420817 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-05-20

No results posted yet for this study

Summary

Lifestyle medicine is a medical specialty that uses evidence-based therapeutic interventions to prevent, treat, and reverse chronic conditions. Studies have shown that a 50 mg/dl reduction in LDL reduces the risk of developing stroke by 20%, and a 10 mm Hg reduction in systolic BP reduces the risk of developing MACE by 22% and stroke by 41%. The CLIP (Cholesterol Lowering Lifestyle Intervention Project) is an innovative initiative proposed to evaluate the combined effect of an Indian version of Portfolio diet-based nutrition strategy, intermittent fasting, exercise, sleep, and stress reduction techniques on lowering blood lipid levels in health professionals and their family. The study aims to evaluate the effect of CLIP on changes in blood pressure, weight, HbA1C levels, blood CRP levels, and other blood parameters.

Conditions

  • Lifestyle Risk Reduction
  • Cholesterol, Elevated
  • LDL Hyperlipoproteinemia
  • Hypertension
  • Lipoprotein(A)
  • HbA1C
  • BMI

Interventions

BEHAVIORAL

Indian version of a 'Portfolio' diet

The participants will be required to follow the prescribed diet plan for 4 weeks

BEHAVIORAL

Physical Activity

The participants will be required to join for an hour of group online exercise program 3 days a week for 4 weeks • (Exercise Duration = 180 minutes per week including cardio, strength training and flexibility)

BEHAVIORAL

Intermittent fasting

The participants will be required to do intermittent fasting for 12 hours daily for 4 weeks

BEHAVIORAL

Monitoring of sleep and stress levels

The participants will be required to monitor their sleep and stress levels

Sponsors & Collaborators

  • Christian Medical College, Vellore, India

    collaborator OTHER

  • Jubilee Mission Medical College and Research Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2024-05-31
Completion
2024-08-15

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420817 on ClinicalTrials.gov